MINNEAPOLIS – March 6, 2023 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that Palmetto GBA has published a final Local Coverage Determination...
MINNEAPOLIS – February 22, 2023 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that the North American Spine Society (NASS) issued a formal coverage...
MINNEAPOLIS – January 5, 2023 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that basivertebral nerve (BVN) ablation received a Grade A Quality of...
MINNEAPOLIS – November 8, 2022 – Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that the International Society for the Advancement of Spine Surgery...
MINNEAPOLIS – October 26, 2022 – Relievant Medsystems, a company focused on transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that its Intracept® Procedure has received the Most Promising New...
The August issue of Pain Medicine includes several peer-reviewed articles focusing on vertebrogenic pain – defining patient, clinical, and imaging factors associated with basivertebral nerve (BVN) ablation treatment success following the Intracept Procedure; and a...